Skip to main content
博迅生物 logo

博迅生物 — Investor Relations & Filings

Ticker · 920504 Beijing Stock Exchange Manufacturing
Filings indexed 301 across all filing types
Latest filing 2024-08-20 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920504

About 博迅生物

http://www.boxun.com.cn/

Boxun Medical Biological Instrument Corp. specializes in the development and manufacture of laboratory equipment and medical instruments. The company's core product line includes high-pressure steam sterilizers, constant temperature incubators, CO2 incubators, drying ovens, and environmental test chambers. These instruments are designed for applications in life sciences, healthcare, pharmaceutical research, and environmental monitoring. Boxun focuses on delivering precise thermal control and reliable sterilization solutions, ensuring compliance with international quality standards. Its equipment is utilized in scientific research, clinical diagnostics, and industrial quality control to maintain sterile environments and stable experimental conditions. The company emphasizes technical innovation and product durability to support the requirements of modern laboratory facilities.

Recent filings

Filing Released Lang Actions
第三届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 19th meeting of the 3rd Board of Directors of Shanghai Boxun Medical Biological Instruments Co., Ltd. It details the meeting's attendance, agenda items, and voting results. The document references several reports and announcements (e.g., 2024 semi-annual report, fundraising usage report, organizational structure adjustment, seal management rules) that are disclosed separately on the Beijing Stock Exchange information platform. The document itself does not contain the full reports or detailed financial data but rather summarizes the board meeting decisions and approvals. This fits the definition of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document is relatively short (2116 characters) and serves as a meeting resolution announcement rather than a full report or financial statement. Therefore, the correct classification is MANG with high confidence.
2024-08-20 Chinese
第三届监事会第十五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Shanghai Boxun Medical Biological Instruments Co., Ltd. It details the meeting date, attendance, and the approval of two proposals: the 2024 semi-annual report and its summary, and a special report on the use of raised funds. The document references that the actual reports are disclosed separately on the Beijing Stock Exchange information platform with specific announcement numbers. The document itself does not contain the financial data or the full reports but announces the resolutions passed regarding these reports. The document length is short (1328 characters) and serves as a meeting resolution announcement rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice, not as the semi-annual report (IR) or any other detailed report type.
2024-08-20 Chinese
印章管理办法
Governance Information Classification · 95% confidence The document is titled as a management system or internal regulation regarding the company's seal (印章) management. It details the rules, responsibilities, and procedures for the use, custody, and control of company seals. It is approved by the board of directors and is a governance-related internal policy document. There is no financial data, no shareholder voting results, no earnings or annual report content, no legal proceedings, no capital or financing updates, no merger or acquisition information, and no regulatory filing or announcement of a report. The document is about internal governance practices and board-approved company policies. Therefore, it fits best under Governance Information (CGR). The document length is 2699 characters, which is relatively short but contains substantive governance content, not just an announcement or notice. Hence, the classification is CGR with high confidence.
2024-08-20 Chinese
募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集资金存放与实际使用情况的专项报告" which translates to a "Special Report on the Deposit and Actual Use of Raised Funds." It details the amount of funds raised through a public offering, the timing of fund receipt, usage amounts, balances, and management of the raised funds. It includes detailed financial figures on fundraising, usage, and cash management, as well as compliance with regulatory requirements and internal approvals. The document is not a full annual or interim financial report but a specific report focused on the use and management of capital raised through equity issuance. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length (6683 characters) and detailed financial data support it being a substantive report rather than a mere announcement. Therefore, the appropriate classification is CAP.
2024-08-20 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "半年度报告 (摘要) -2024-" which translates to "Half-Year Report (Summary) - 2024." It contains detailed financial data for the reporting period, including assets, liabilities, net profit, earnings per share, and other financial metrics. It also includes company business descriptions, shareholder information, and notes on asset pledges. The document explicitly states it is a half-year report and includes substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is 5480 characters, which is sufficient to contain actual financial data rather than just a brief announcement. Hence, the classification is IR with high confidence. H1 2024
2024-08-20 Chinese
2024年半年度报告
Interim / Quarterly Report Classification · 98% confidence The document is titled as a "半年度报告" which translates to "Half-Year Report" or "Interim Report". It covers the period from 2024.01.01 to 2024.06.30, indicating it is a report for a period shorter than a full fiscal year. The content includes detailed financial data such as income, profit, assets, liabilities, and operational analysis, which are typical components of an interim or quarterly report. The document is about 15,000 characters long, which is substantial and contains actual financial statements and analysis, not just an announcement or summary. There is no indication that this is an annual report (10-K), earnings release (ER), or other types of filings. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-20 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.